Millennium Management
BOLT icon

Millennium Management’s Bolt Biotherapeutics BOLT Stock Holding History

Millennium Management’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,351
Closed -$25.2K – 5881
2024
Q4 		$25.2K Buy
+2,351
New +$28.4K ﹤0.01% 5687
2024
Q2 		– Sell
-2,298
Closed -$64.3K – 5911
2024
Q1 		$64.3K Sell
2,298
-52
-2% -$1.2K ﹤0.01% 5650
2023
Q4 		$52.6K Buy
2,350
+101
+4% +$1.97K ﹤0.01% 5463
2023
Q3 		$46.8K Sell
2,249
-3,450
-61% -$84.3K ﹤0.01% 5493
2023
Q2 		$146K Sell
5,699
-6,572
-54% -$209K ﹤0.01% 5234
2023
Q1 		$341K Buy
12,271
+101
+0.8% +$2.96K ﹤0.01% 4823
2022
Q4 		$316K Buy
12,170
+6,251
+106% +$171K ﹤0.01% 5053
2022
Q3 		$175K Sell
5,919
-3,674
-38% -$152K ﹤0.01% 5735
2022
Q2 		$391K Buy
+9,593
New +$372K ﹤0.01% 5148
2021
Q4 		– Sell
-8,157
Closed -$2.06M – 6806
2021
Q3 		$2.06M Buy
8,157
+6,558
+410% +$1.85M ﹤0.01% 3872
2021
Q2 		$494K Buy
+1,599
New +$649K ﹤0.01% 5321

Other funds holding BOLT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's BOLT Position: Q1 2025 in Review

Millennium Management sold out of Bolt Biotherapeutics (BOLT) in Q1 2025, closing a stake of 2,351 shares — an estimated $25.2K sold.

Millennium Management first reported a position in BOLT in Q2 2021 and held it in 11 quarters. The position peaked at $2.06M in Q3 2021. 29 funds tracked by Wall St. Rank hold BOLT as of Q1 2025.

  • Millennium Management reported no remaining Bolt Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 2,351 Bolt Biotherapeutics shares in Q1 2025, an estimated $25.2K.
  • Millennium Management first reported a position in Bolt Biotherapeutics in Q2 2021 and held it in 11 quarters.
  • Millennium Management's Bolt Biotherapeutics position peaked at $2.06M in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.